Method for treating and controlling the symptoms of neurodegenerative disease and neuropsychopharmacological disorders
US5256690A · kind A · utility
2Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 26, 1992 |
| Grant date | Oct 26, 1993 |
| Priority date | — |
| Expiry date | Oct 26, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating and controlling the symptoms of neuropsychopharmacological disorders and neurodegenerative diseases associated with or resulting from excessive activation of the N-methyl-D-aspartate receptor complex which comprises administering to warm-blooded animals in need of such treatment, 2-phenyl-1,3-propanediol dicarbamate, the neuroprotective effects of which are at least partially mediated through a strychnine-insensitive glycine receptor mechanism is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.